Seung Ho Hur
Overview
Explore the profile of Seung Ho Hur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
1110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jo J, Lee S, Joh H, Kim H, Kim J, Hong Y, et al.
Crit Care
. 2025 Feb;
29(1):65.
PMID: 39915828
Background: Although potent P2Y inhibitors, such as ticagrelor and prasugrel, are standard treatment in patients with acute myocardial infarction (AMI), evidence for their efficacy and safety compared with clopidogrel is...
2.
Joh H, Lee S, Jo J, Kim H, Lim W, Kim H, et al.
Rev Esp Cardiol (Engl Ed)
. 2024 Apr;
77(12):995-1007.
PMID: 38609042
Introduction And Objectives: There are no clinical data on the efficacy of intravascular imaging-guided percutaneous coronary intervention (PCI) compared with angiography-guided PCI in patients with acute myocardial infarction (AMI) and...
3.
Kim C, Lee S, Kim H, Kim M, Kim J, Hong Y, et al.
Circ J
. 2024 Apr;
88(8):1237-1245.
PMID: 38599833
Background: Limited data exist regarding the prognostic implications of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with non-ST-elevation myocardial infarction (NSTEMI) who undergo percutaneous coronary intervention (PCI). Methods and results:...
4.
Kim H, Kang D, Ahn J, Lee J, Choi Y, Hur S, et al.
JACC Cardiovasc Interv
. 2023 Oct;
16(19):2412-2422.
PMID: 37821187
Background: Diabetes mellitus is associated with more complex coronary artery diseases. Coronary artery bypass grafting (CABG) is a preferred revascularization strategy over percutaneous coronary intervention (PCI) in diabetics with multivessel...
5.
Bae S, Cha J, Lim S, Kim J, Joo H, Park J, et al.
JACC Cardiovasc Interv
. 2023 Jan;
16(1):64-75.
PMID: 36599589
Background: A limitation of the current guidelines regarding the timing of invasive coronary angiography for patients with non-ST-segment elevation acute coronary syndrome is the randomization time. To date, no study...
6.
Ahn J, Kang D, Yun S, Hur S, Park H, Tresukosol D, et al.
Circulation
. 2022 Sep;
146(21):1581-1590.
PMID: 36121700
Background: Long-term comparative outcomes after percutaneous coronary intervention (PCI) with everolimus-eluting stents and coronary artery bypass grafting (CABG) are limited in patients with multivessel coronary artery disease. Methods: This prospective,...
7.
Lee S, Jeong M, Ahn J, Hyun D, Cho K, Kim M, et al.
Korean J Intern Med
. 2022 Jul;
37(4):777-785.
PMID: 35811366
Background/aims: Recurrent acute myocardial infarction (AMI) is an adverse cardiac event in patients with a first AMI. The predictors of recurrent AMI after the first AMI in patients who underwent...
8.
Kang M, Kim W, Kim J, Jeong K, Jeong M, Hwang J, et al.
J Am Heart Assoc
. 2022 Jun;
11(11):e024649.
PMID: 35656978
Background Hydrophilic and lipophilic statins have similar efficacies in treating coronary artery disease. However, specific factors relevant to renal impairment and different arterial pathogeneses could modify the clinical effects of...
9.
Cho K, Shin M, Kim M, Sim D, Hong Y, Kim J, et al.
J Lipid Atheroscler
. 2022 Jun;
11(2):147-160.
PMID: 35656148
Objective: Data pertaining to the prognostic value of the combination of high neutrophil-to-lymphocyte ratio (NLR) and anemia on admission in patients with ST-segment elevation myocardial infarction (STEMI) are limited. The...
10.
Yoon C, Jang J, Hur S, Lee J, Han S, Hong S, et al.
Korean Circ J
. 2022 Feb;
52(5):354-364.
PMID: 35129319
Background And Objectives: To compare the safety and efficacy of a new everolimus-eluting stent with an abluminal-coated biodegradable polymer (Osstem Cardiotec Centum) with those of the Xience Alpine stent (Xience)....